Cited by 113Atrial Fibrillation Management and OutcomesHeart Failure Treatment and ManagementCardiac Health and Mental Health

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Digoxin and mortality in atrial fibrillation: a prospective cohort study

Hallberg, Pär, Lindbäck, Johan, Lindahl, Bertil, Stenestrand, Ulf, Melhus, Håkan, for the RIKS-HIA group·2007·European Journal of Clinical Pharmacology

DOI 10.1007/s00228-007-0346-9

Open this paper in CoChat — free account

Abstract

Objective The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study showed that rhythm-control treatment of patients with atrial fibrillation (AF) offered no survival advantage over a rate-control strategy. In a subgroup analysis of that study, it was found that digoxin increased the death rate [relative risk (RR) = 1.42), but it was suggested that this may have been attributable to prescription of digoxin for patients at greater risk of death, such as those with congestive heart failure (CHF). No study has investigated a priori the effect of digoxin on mortality in patients with AF. This study aimed to address this question.Methods Using data from the Registry of Information and Knowledge about Swedish Heart Intensive care Admissions (RIKS-HIA), we studied the 1-year mortality among patients admitted to coronary care units with AF, CHF, or AF+CHF with or without digoxin (n = 60,764) during 1995-2003. Adjustment for differences in background characteristics and other medications and treatments was made by propensity scoring.Results Twenty percent of patients with AF without CHF in this cohort were discharged with digoxin. This group had a higher mortality rate than the corresponding group not given digoxin [adjusted RR 1.42 (95% CI 1.29-1.56)], whereas no such difference was seen among patients with CHF with or without AF, although these patients had a nearly three-times higher mortality.Conclusion The results suggest that long-term therapy with digoxin is an independent risk factor for death in patients with AF without CHF.

Integrity signals

Registry

Crossref · 10.1007/s00228-007-0346-9

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The central role of the propensity score in observational studies for causal effects
ROSENBAUM, P. R., & RUBIN, D. B. (1983) · Biometrika · doi:10.1093/biomet/70.1.41 · Cited by 31,241
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369
A comparison of rate control and rhythm control in patients with atrial fibrillation
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa021328 · Cited by 4,405
Estimating Causal Effects from Large Data Sets Using Propensity Scores
Rubin, D. V. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-8_part_2-199710151-00064 · Cited by 3,104
The effect of digoxin on mortality and morbidity in patients with heart failure
(1997) · New England Journal of Medicine · doi:10.1056/nejm199702203360801 · Cited by 3,016
Relationships Between Sinus Rhythm, Treatment, and Survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study
The AFFIRM Investigators (2004) · Circulation · doi:10.1161/01.cir.0000121736.16643.11 · Cited by 1,202
Invited commentary: propensity scores.
Joffe, M., & Rosenbaum, P. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010011 · Cited by 1,117
Predictors of mortality and morbidity in patients with chronic heart failure
Pocock, S., Wang, D., Pfeffer, M. A., Yusuf, S., McMurray, J. J. V., Swedberg, K. B., Östergren, J., Michelson, E. L., Pieper, K. S., & Granger, C. B. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi555 · Cited by 972
Risk of Death in Elderly Users of Conventional vs. Atypical Antipsychotic Medications
Wang, P. S., Schneeweiss, S., Avorn, J., Fischer, M. A., Mogun, H., Solomon, D. H., & Brookhart, M. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052827 · Cited by 959
Digoxin in Heart Failure with a Reduced Ejection Fraction: A Risk Factor or a Risk Marker?
Konstantinou, D. M., Karvounis, H. I., & Giannakoulas, G. A. (2016) · Cardiology · doi:10.1159/000444078 · Cited by 881
Withdrawal of Digoxin from Patients with Chronic Heart Failure Treated with Angiotensin-Converting-Enzyme Inhibitors
Packer, M., Gheorghiade, M., Young, J. B., Costantini, P. J., Adams, K. F., Cody, R. J., Smith, L. K., Voorhees, L. V., Gourley, L. A., & Jolly, M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307013290101 · Cited by 830
Association of Serum Digoxin Concentration and Outcomes in Patients With Heart Failure
Rathore, S. S., Curtis, J. P., Wang, Y., Bristow, M. R., & Krumholz, H. M. (2003) · JAMA · doi:10.1001/jama.289.7.871 · Cited by 772
Sex-Based Differences in the Effect of Digoxin for the Treatment of Heart Failure
Rathore, S. S., Wang, Y., & Krumholz, H. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021266 · Cited by 688
Withdrawal of Digoxin from Patients with Chronic Heart Failure Treated with Angiotensin-Converting-Enzyme Inhibitors
O'Mara, N. B., & Zimmerman, W. B. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312093292417 · Cited by 639
Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: Results of the PROVED trial
Uretsky, B. F., Young, J. B., Shahidi, F. E., Yellen, L., Harrison, M., & Jolly, M. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90403-n · Cited by 580
Early Statin Treatment Following Acute Myocardial Infarction and 1-Year Survival
Stenestrand, U. (2001) · JAMA · doi:10.1001/jama.285.4.430 · Cited by 531
Self-citation
Guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology
Fuster, V., Rydén, L., ASINGER, R. W., Cannom, D. S., Crijns, H. J. G. M., Frye, R. L., Halperin, J. L., Kay, G. N., Klein, W. W., Lévy, S., et al. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2983 · Cited by 491
Lipid-Lowering Therapy and In-Hospital Mortality Following Major Noncardiac Surgery
Lindenauer, P. K. (2004) · JAMA · doi:10.1001/jama.291.17.2092 · Cited by 467
Digoxin for Converting Recent-Onset Atrial Fibrillation to Sinus Rhythm
Falk, R. H., Knowlton, A. A., Bernard, S. A., Gotlieb, N. E., & Battinelli, N. J. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-4-503 · Cited by 335
Relationship of Serum Digoxin Concentration to Mortality and Morbidity in Women in the Digitalis Investigation Group Trial
Adams, K. F., Patterson, J. H., Gattis, W. A., O’Connor, C. M., Lee, C. R., Schwartz, T. A., & Gheorghiade, M. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.02.091 · Cited by 293
Propensity Analysis of Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Multivessel Coronary Artery Disease and High-Risk Features
Brener, S. J., Lytle, B. W., Casserly, I. P., Schneider, J. P., Topol, E. J., & Lauer, M. S. (2004) · Circulation · doi:10.1161/01.cir.0000126826.58526.14 · Cited by 265
Association between antenatal cytokine production and the development of atopy and asthma at age 6 years
Macaubas, C., de Klerk, N., Holt, B., Wee, C., Kendall, G., Firth, M., Sly, P., & Holt, P. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14542-4 · Cited by 232
Digoxin. A neurohormonal modulator in heart failure?
Gheorghiade, M., & Ferguson, D. W. (1991) · Circulation · doi:10.1161/01.cir.84.5.2181 · Cited by 197
Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone
Hou, Z., Chang, M.-S., CHEN, C., TU, M.-S., Lin, S., CHIANG, H.-T., & Woosley, R. L. (1995) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060945 · Cited by 178
Digoxin
Eichhorn, E. J., & Gheorghiade, M. (2002) · Progress in Cardiovascular Diseases · doi:10.1053/pcad.2002.31591 · Cited by 151
Intravenous digoxin in acute atrial fibrillation: Results of a randomized, placebo-controlled multicentre trial in 239 patients
The Digitalis in Acute Atrial Fibrillation (DAAF) Trial Group (1997) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015311 · Cited by 150
Conversion of atrial fibrillation to sinus rhythm and rate control by digoxin in comparison to placebo
Jordaens, L. J. L. M., Trouerbach, J., Calle, P., Tavernier, R., Derycke, E., Vertongen, P., Bergez, B. M., & Vandekerckhove, Y. R. (1997) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015310 · Cited by 145
To what extent do congestive heart failure patients in sinus rhythm benefit from digoxin therapy? A systematic overview and meta-analysis
Jaeschke, R., Guyatt, G. H., & Oxman, A. D. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90154-6 · Cited by 117
Early revascularisation and 1-year survival in 14-day survivors of acute myocardial infarction: a prospective cohort study
Stenestrand, U., & Wallentin, L. C. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08710-x · Cited by 114
Self-citation
Relation of left ventricular function and Na,K-pump concentration in suspected idiopathic dilated cardiomyopathy
Nørgaard, A., Bagger, J. P., Bjerregaard, P., Baandrup, U. T., Kjeldsen, K. P., & Thomsen, P. E. B. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)91175-7 · Cited by 94
Digoxin Assays: Frequent, Substantial, and Potentially Dangerous Interference by Spironolactone, Canrenone, and Other Steroids
Steimer, W., Müller, C., & Eber, B. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.3.507 · Cited by 92
Comorbidity and Myocardial Dysfunction Are the Main Explanations for the Higher 1-Year Mortality in Acute Myocardial Infarction With Left Bundle-Branch Block
Stenestrand, U., Tabrizi, F., Lindbäck, J., Englund, A., Rosenqvist, M., & Wallentin, L. C. (2004) · Circulation · doi:10.1161/01.cir.0000143136.51424.38 · Cited by 87
Self-citation
Fibrinolytic Therapy in Patients 75 Years and Older With ST-Segment–Elevation Myocardial Infarction One-Year Follow-up of a Large Prospective Cohort
Stenestrand, U. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.8.965 · Cited by 77
Self-citation
Efficacy and safety ofdigoxin alone and in combination with low-dosediltiazem orbetaxolol to control ventricular rate in chronic atrial fibrillation
Koh, K. K., Kwon, K. S., Park, H. B., Baik, S. H., Park, S. J., Lee, K. H., Kim, E. J., Kim, S. H., Cho, S. K., & Kim, S. S. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80538-4 · Cited by 61
CLINICAL PHARMACOLOGY OF DIGOXIN
Gold, H., Cattell, M., GREINER, T. H., Hanlon, L. W., Kwit, N. T., Modell, W., Cotlove, E. W., Benton, J. G., & Otto, H. L. (1953) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)05217-6 · Cited by 58
The effect of digoxin on the quality of life in patients with heart failure
Lader, E. W., Egan, D., Hunsberger, S., Garg, R., Czajkowski, S. M., & McSherry, F. (2003) · Journal of Cardiac Failure · doi:10.1054/jcaf.2003.7 · Cited by 56
New insights into the mechanisms and management of atrial fibrillation.
Khairy, P., & Nattel, S. (2002) · Europe PMC (PubMed Central) · Cited by 45
Safety concerns about digoxin after acute myocardial infarction
Spargias, K. S., Hall, A. S., & Ball, S. G. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01429-4 · Cited by 39
THE EFFECT OF DIFFERENT DIGOXIN DOSES ON SUBJECTIVE SYMPTOMS AND PHYSICAL WORKING CAPACITY IN PATIENTS WITH ATRIAL FIBRILLATION
Redfors, A. (1971) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1971.tb07436.x · Cited by 35
Association Between Antenatal Cytokine Production and the Development of Atopy and Asthma at Age 6 Years
Macaubas, C., de Klerk, N. H., Holt, B. J., Wee, C., Kendall, G. E., Firth, M., Sly, P. D., & Holt, P. G. (2004) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000119184.27552.59 · Cited by 34
Digoxin for chronic heart failure: A review of the randomized controlled trials with special attention to the PROVED and RADIANCE trials
Tauke, J. T., Goldstein, S., & Gheorghiade, M. (1994) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(05)80051-9 · Cited by 28
Use of Cardiovascular Drugs in an Older Swedish Population
Wills, P., Fastbom, J., Claesson, C. B., Cornelius, C., Thorslund, M., & Winblad, B. G. (1996) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1996.tb05638.x · Cited by 22
Effects of Long-Term Digoxin Therapy on Heart Rate Variability, Baroreceptor Sensitivity, and Exercise Capacity in Patients with Heart Failure
Vardas, P. E., KANOUPAKIS, E. M., KOCHIADAKIS, G. E., SIMANTIRAKIS, E. N., Marketou, M. E., & CHLOUVERAKIS, G. I. (1998) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1007785314462 · Cited by 16
Was it Digoxin Toxicity?…Very Likely
Ruelaz, R. A., & Rahimtoola, S. H. (2005) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2004.11.001 · Cited by 15

Sorted by citations

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström‐Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 10,550
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P. F., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castellà, M., Diener, H., Heidbüchel, H., Hendriks, J., et al. (2016) · EP Europace · doi:10.1093/europace/euw295 · Cited by 6,438
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezw313 · Cited by 1,403
Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data
Ziff, O. J., Lane, D. A., Samra, M., Griffith, M., Kirchhof, P., Lip, G. Y. H., Steeds, R. P., Townend, J., & Kotecha, D. (2015) · BMJ · doi:10.1136/bmj.h4451 · Cited by 341

See all 113

Authors: Hallberg, P., Lindbäck, J., Lindahl, B., Stenestrand, U., Melhus, H., & for the RIKS-HIA group
Affiliations: Uppsala University (SE)
Linköping University Hospital (SE)
Corresponding author: Hallberg, Pär
ORCID: Hallberg, Pär
Lindbäck, Johan
Lindahl, Bertil
Melhus, Håkan
Venue: European Journal of Clinical Pharmacology
Publisher: Springer Science and Business Media LLC
Published: 2007-08-08
Volume: 63
Issue: 10
Pages: 959-971
ISSN: 0031-6970 (ISSN-L)
1432-1041
DOI: 10.1007/s00228-007-0346-9
OpenAlex: W1967375232
Cited by: 113
References: 44
Citations by year: 2025: 2 · 2024: 2 · 2022: 5 · 2021: 8 · 2020: 7 · 2019: 5 · 2018: 8 · 2017: 4 · 2016: 16 · 2015: 19 · 2014: 10 · 2013: 4 · 2012: 5
FWCI: 3.51
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: European Journal of Clinical Pharmacology (publishedVersion)
PubMed (publishedVersion)
Funders: Hjärt-Lungfonden
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
Keywords: digoxin, atrial fibrillation, mortality, congestive heart failure, coronary care unit admission, rhythm control, rate control, cardiovascular risk factors
MeSH terms: Aged, Aged, 80 and over, Anti-Arrhythmia Agents, Atrial Fibrillation, Creatinine, Digoxin, Female, Heart Failure, Humans, Male, Myocardial Infarction, Prospective Studies, Registries, Research Design, Risk Factors, Stroke Volume, Sweden, Time Factors, Proportional Hazards Models, Ventricular Function, Left, Treatment Outcome, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Digoxin and mortality in atrial fibrillation: a prospective cohort study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks